Mariner’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $286M | Sell |
1,316,270
-54,123
| -4% | -$12M | 0.33% | 51 |
|
|
2025
Q4 | $313M | Buy |
1,370,393
+30,704
| +2% | +$6.99M | 0.37% | 43 |
|
|
2025
Q3 | $310M | Buy |
1,339,689
+175,406
| +15% | +$35.7M | 0.4% | 42 |
|
|
2025
Q2 | $216M | Buy |
1,164,283
+53,786
| +5% | +$10M | 0.31% | 60 |
|
|
2025
Q1 | $233M | Buy |
1,110,497
+27,638
| +3% | +$5.37M | 0.39% | 49 |
|
|
2024
Q4 | $192M | Buy |
1,082,859
+25,669
| +2% | +$4.72M | 0.32% | 59 |
|
|
2024
Q3 | $209M | Buy |
1,057,190
+34,440
| +3% | +$6.43M | 0.37% | 54 |
|
|
2024
Q2 | $175M | Buy |
1,022,750
+36,711
| +4% | +$6.08M | 0.34% | 61 |
|
|
2024
Q1 | $180M | Sell |
986,039
-3,845
| -0.4% | -$663K | 0.37% | 57 |
|
|
2023
Q4 | $153M | Buy |
989,884
+45,835
| +5% | +$6.68M | 0.36% | 59 |
|
|
2023
Q3 | $141M | Buy |
944,049
+45,294
| +5% | +$6.65M | 0.38% | 62 |
|
|
2023
Q2 | $121M | Buy |
898,755
+23,804
| +3% | +$3.49M | 0.32% | 72 |
|
|
2023
Q1 | $139M | Buy |
874,951
+46,528
| +6% | +$7.11M | 0.41% | 55 |
|
|
2022
Q4 | $134M | Buy |
828,423
+104,993
| +15% | +$16.1M | 0.43% | 54 |
|
|
2022
Q3 | $97.1M | Buy |
723,430
+38,847
| +6% | +$5.57M | 0.39% | 62 |
|
|
2022
Q2 | $105M | Buy |
684,583
+75,061
| +12% | +$11.5M | 0.43% | 58 |
|
|
2022
Q1 | $98.8M | Buy |
609,522
+231,465
| +61% | +$33.6M | 0.37% | 62 |
|
|
2021
Q4 | $51.2M | Buy |
378,057
+55,149
| +17% | +$6.51M | 0.22% | 114 |
|
|
2021
Q3 | $34.8M | Buy |
322,908
+27,303
| +9% | +$3.12M | 0.18% | 140 |
|
|
2021
Q2 | $33.3M | Buy |
295,605
+9,077
| +3% | +$1.02M | 0.21% | 133 |
|
|
2021
Q1 | $31M | Buy |
286,528
+9,929
| +4% | +$1.06M | 0.22% | 128 |
|
|
2020
Q4 | $29.6M | Buy |
276,599
+26,053
| +10% | +$2.5M | 0.23% | 120 |
|
|
2020
Q3 | $21.9M | Sell |
250,546
-271,281
| -52% | -$25.5M | 0.21% | 131 |
|
|
2020
Q2 | $51.2M | Buy |
521,827
+11,567
| +2% | +$1.02M | 0.51% | 44 |
|
|
2020
Q1 | $38.9M | Buy |
510,260
+322,172
| +171% | +$27.4M | 0.49% | 49 |
|
|
2019
Q4 | $16.7M | Buy |
188,088
+19,327
| +11% | +$1.6M | 0.17% | 150 |
|
|
2019
Q3 | $12.8M | Sell |
168,761
-14,257
| -8% | -$977K | 0.15% | 156 |
|
|
2019
Q2 | $13.3M | Buy |
183,018
+36,247
| +25% | +$2.85M | 0.16% | 156 |
|
|
2019
Q1 | $11.8M | Buy |
146,771
+5,490
| +4% | +$449K | 0.17% | 149 |
|
|
2018
Q4 | $13M | Buy |
141,281
+66,362
| +89% | +$5.84M | 0.23% | 122 |
|
|
2018
Q3 | $7.09M | Buy |
74,919
+8,510
| +13% | +$807K | 0.18% | 129 |
|
|
2018
Q2 | $6.15M | Buy |
66,409
+17,296
| +35% | +$1.69M | 0.17% | 130 |
|
|
2018
Q1 | $4.65M | Buy |
49,113
+18,076
| +58% | +$1.99M | 0.17% | 119 |
|
|
2017
Q4 | $3M | Buy |
31,037
+17,167
| +124% | +$1.62M | 0.12% | 152 |
|
|
2017
Q3 | $1.23M | Sell |
13,870
-2,625
| -16% | -$200K | 0.06% | 235 |
|
|
2017
Q2 | $1.2M | Sell |
16,495
-11,681
| -41% | -$785K | 0.06% | 228 |
|
|
2017
Q1 | $1.84M | Sell |
28,176
-533
| -2% | -$33.5K | 0.08% | 203 |
|
|
2016
Q4 | $1.8M | Buy |
28,709
+2,589
| +10% | +$158K | 0.08% | 200 |
|
|
2016
Q3 | $1.65M | Sell |
26,120
-285
| -1% | -$18.4K | 0.08% | 206 |
|
|
2016
Q2 | $1.63M | Buy |
26,405
+1,876
| +8% | +$114K | 0.09% | 193 |
|
|
2016
Q1 | $1.4M | Buy |
24,529
+2,192
| +10% | +$122K | 0.08% | 198 |
|
|
2015
Q4 | $1.32M | Sell |
22,337
-1,489
| -6% | -$85.8K | 0.08% | 186 |
|
|
2015
Q3 | $1.3M | Sell |
23,826
-854
| -3% | -$55.6K | 0.06% | 214 |
|
|
2015
Q2 | $1.66M | Buy |
24,680
+16,881
| +216% | +$1.1M | 0.08% | 194 |
|
|
2015
Q1 | $457K | Buy |
7,799
+6
| +0.1% | +$362 | 0.04% | 261 |
|
|
2014
Q4 | $510K | Buy |
7,793
+104
| +1% | +$6.56K | 0.05% | 243 |
|
|
2014
Q3 | $444K | Sell |
7,689
-4,371
| -36% | -$243K | 0.05% | 227 |
|
|
2014
Q2 | $681K | Buy |
12,060
+1,318
| +12% | +$69.1K | 0.08% | 191 |
|
|
2014
Q1 | $552K | Sell |
10,742
-6,063
| -36% | -$306K | 0.07% | 205 |
|
|
2013
Q4 | $887K | Sell |
16,805
-1,248
| -7% | -$61.3K | 0.11% | 163 |
|
|
2013
Q3 | $807K | Buy |
18,053
+5,518
| +44% | +$245K | 0.15% | 144 |
|
|
2013
Q2 | $518K | Buy |
+12,535
| New | +$548K | 0.11% | 167 |
|
Other funds holding ABBV
VCM
VPM
Mariner's ABBV Position: Q1 2026 in Review
Mariner reduced its AbbVie (ABBV) stake by 3.9% in Q1 2026, selling an estimated $12M and leaving 1,316,270 shares worth $286M. The position accounts for 0.33% of the portfolio, ranked #51.
Mariner first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $313M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Mariner held 1,316,270 shares of AbbVie worth $286M as of Q1 2026.
- Mariner sold 54,123 AbbVie shares in Q1 2026, an estimated $12M.
- AbbVie made up 0.33% of Mariner's portfolio in Q1 2026, its #51 holding.
- Mariner first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Mariner's AbbVie position peaked at $313M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.